Steward Partners Investment Advisory
PAHC icon

Steward Partners Investment Advisory’s Phibro Animal Health PAHC Stock Holding History

Steward Partners Investment Advisory’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$565 Buy
+18
New +$760 ﹤0.01% 4450
2023
Q1 		– Sell
-67
Closed -$898 – 3393
2022
Q4 		$898 Buy
+67
New +$898 ﹤0.01% 3132

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steward Partners Investment Advisory's PAHC Position: Q2 2026 in Review

Steward Partners Investment Advisory opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 18 shares worth $565. The stake represents ﹤0.01% of the portfolio and ranks #4450 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in PAHC as recently as Q4 2022.

Steward Partners Investment Advisory first reported a position in PAHC in Q4 2022 and has held it in 2 quarters since. The position peaked at $898 in Q4 2022. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Steward Partners Investment Advisory held 18 shares of Phibro Animal Health worth $565 as of Q2 2026.
  • Phibro Animal Health was a new Steward Partners Investment Advisory position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4450 holding.
  • Steward Partners Investment Advisory first reported a position in Phibro Animal Health in Q4 2022 and has held it in 2 quarters since.
  • Steward Partners Investment Advisory's Phibro Animal Health position peaked at $898 in Q4 2022.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.